Abstract #1860

Changes in breast tumor blood flow measured by dynamic contrast-enhanced MRI after one cycle of neoadjuvant chemotherapy

William Stevens¹, Leonidas Georgiou¹, Andrew M. Hanby¹, Daniel J. Wilson², Nisha Sharma², Timothy J. Perren¹, David Dodwell², Barbara J. Dall², and David L. Buckley¹

¹University of Leeds, Leeds, United Kingdom, ²Leeds Teaching Hospitals NHS Trust, Leeds, United Kingdom

Early assessment of response to neoadjuvant chemotherapy (NACT) in breast cancer is important and it has been suggested that functional changes, such as tumor blood flow (TBF), may precede size changes. We measured TBF using dynamic contrast-enhanced MRI in 40 patients before and after one cycle of NACT and compared these measures to pathological response. There was no correlation between change in TBF and pathological response in the full sample. However, several tumors shrank after one cycle of NACT; if these were removed then change in TBF in tumors that didn’t shrink correlated well with pathological response

How to access this content:

For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.

After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.

After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.

Click here for more information on becoming a member.